twoXAR Pharmaceuticals

Jun 22, 2020

twoXAR Pharmaceuticals Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311

Jun 03, 2020

Howard Rosen Joins twoXAR Pharmaceuticals' Board of Directors

Mar 03, 2020

twoXAR Pharmaceuticals Announces Appointment of Mark Eller, Ph.D. as Senior Vice President of Research and Development and Anjali Pandey, Ph.D. as Senior Vice President of Nonclinical R&D and Chemistry